doranidazole has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, T; Inanami, O; Kino, J; Kubota, N; Kuwabara, M; Meike, S; Nagane, M; Yamamori, T; Yasui, H | 1 |
1 other study(ies) available for doranidazole and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Death; Cell Line, Tumor; Disease Models, Animal; Glioblastoma; Imidazoles; Prospective Studies; Radiation-Sensitizing Agents; Rats | 2013 |